FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to an immunostimulatory composition containing a) an adjuvant component containing or consisting of at least one (m)RNA combined with a polycationic peptide or a protein, and b) at least one free mRNA coding at least one antigen with immunostimulatory composition being able to induce or improve the innate or optionally adaptive immune response in a mammal. The molar ration of (m)RNA of the adjuvant component a) to at least one free mRNA of the second component b) of the immunostimulatory composition falls within the range of approximately 0.001:1 to approximately 1:0.001. The immunostimulatory composition according to the present invention can be both a pharmaceutical composition, and a vaccine. The group of inventions also refers to a method for preparing the immunostimulatory composition and using it for treating various diseases.
EFFECT: group of inventions is effective in inducing and improving the immune response in the mammal, as well as in preventing and treating the diseases and disorders specified in a group consisting of tumour, autoimmune, infectious and allergic diseases.
22 cl, 2 tbl, 14 dwg, 11 ex
